A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

An Ozempic-like drug used to treat diabetes, called lixisenatide, helped slow the progression of motor disability in patients in an early stage of Parkinson's disease, according to the results of ...

A rigorous study that randomly assigned Parkinson’s patients to take exenatide, a relative of Ozempic, showed absolutely no benefit or slowing of the course of the degenerative disease after 96 ...

People with type 2 diabetes who used semaglutide (Ozempic) versus other drugs had a lower risk of Alzheimer's disease and ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's disease have taken an hit.

Could a medication similar to the blockbuster weight-loss drugs Ozempic and Wegovy slow the ravages of Parkinson's disease?. A new, small study suggests it could: Over the course of a year, a ...

An Ozempic Relative Slowed Parkinson’s Disease in a Small Study. The trial lasted only one year but offered embers of hope to some experts. Listen to this article · 5:19 min Learn more.

Canadian endocrinologist Daniel J. Drucker — a diabetes treatment pioneer whose work paved the way for Ozempic — is sharing what's next for these obesity and diabetes drugs.

A GLP-1 receptor agonist commonly used to treat type 2 diabetes could help reduce the development of motor skills deterioration in people with early-stage Parkinson’s, a new study indicates.

In this Oct. 31, 2023 file photo, a box of Ozempic and contents sit on a table in Dudley ... can also lower the risk of other neurodegenerative diseases, including Parkinson's disease and Lewy body ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite earlier hopes, a rigorous 96-week trial with 194 participants found no ...

GLP-1 drugs like Ozempic do not slow Parkinson's disease, study finds The trial showed no benefit in symptoms or brain scans Experts say more research is needed before using these drugs for brain ...